{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:30:56Z","timestamp":1755793856844,"version":"3.37.3"},"reference-count":27,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T00:00:00Z","timestamp":1226448000000},"content-version":"vor","delay-in-days":4090,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[1997,9]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>Despite treatment with intensive immunosup\u2010pressive drug regimens, the prognosis of patients suffering from severe progressive autoimmune diseases like systemic lupus erythematosus (SLE), nephrotic syndrome (NS), and Behqet's disease is poor. Side effects (infections and malignant tumors) often occur. In the present trial, 35 patients suffering from autoimmune diseases (SLE, n = 21; NS, n = 10; and Behqet's disease, n = 4) were treated for 3.7 \u00b1 2.0 years with 2.5 \u00b1 0.6 mg cyclosporine\/kg body weightlday in addition to corticosteroids alone or in combination with azathioprine and\/or cyclophosphamide. In active stages of the diseases with extremely high concentrations of anti\u2010ds\u2010DNA\u2010antibodies, antinuclear antibodies, circulating immunocomplexes, and reduced complement concentrations, therapeutic plasma exchange (TPE) has been applied. Compared with previous treatment mo dalities, significantly (p &lt; 0.05) more effective and rapid reductions of the antibodies were reached. Clinical disorders improved within 1\u20136 weeks. All patients reported increased performance and a better quality of life. After 1\u201312 months, the previously required doses of immuno\u2010suppressive drugs and the frequency of TPE could be reduced by 40\u2013100%. After 13.4 \u00b1 11.8 months in 17 of 35 patients (8 with SLE, 5 with NS, 4 with Behqet's disease), cyclosporine was established as the monotherapy. No severe side effects were registered. In treating active stages of severe progressive autoimmune diseases and forms with persistent high antibody levels, the addition of TPE to conventional therapy was very effective, as observed in both clinical and laboratory parameters.<\/jats:p>","DOI":"10.1111\/j.1525-1594.1997.tb00512.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T21:00:34Z","timestamp":1279746034000},"page":"983-988","source":"Crossref","is-referenced-by-count":9,"title":["Cyclosporine and Therapeutic Plasma Exchange in Treatment of Progressive Autoimmune Diseases"],"prefix":"10.1111","volume":"21","author":[{"given":"Ralf","family":"Schiel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Bambauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Latza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Klinkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,11,12]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"381","article-title":"Sur I'h\u00e9molyse par les glycosides globulicides et les conditions de milieu qui la favorisent ou l'emp\u00eachent","volume":"7","author":"Hedon E.","year":"1901","journal-title":"Arch Intern Pharmacol Gand Paris"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-3565(25)08256-4","article-title":"Plasma removal with return of corpuscles (plasmapheresis)","volume":"5","author":"Abel JJ","year":"1914","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199305050-00006"},{"key":"e_1_2_1_5_2","first-page":"233","article-title":"Immune complexes: Their formation and role in pathogenesis of disease","volume":"4","author":"Jones VJ","year":"1983","journal-title":"Plasma Ther Transfus Technol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199305050-00005"},{"issue":"1","key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0889-857X(21)00372-0","article-title":"Severe major organ involvement in systemic lupus erythematosus. Diagnosis and management","volume":"21","author":"Fessler BJ","year":"1995","journal-title":"Rheum Dis Clin North Am"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92381-7"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603063141004"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198806023182203"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80463-9"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340803"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(80)80078-7"},{"key":"e_1_2_1_14_2","first-page":"530","article-title":"Wirkungsmechanismus des Ciclosporin A","volume":"26","author":"Wagner H.","year":"1985","journal-title":"Internist"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068710"},{"volume-title":"Sandimmum (Ciclosporin)","year":"1990","author":"Sandoz AG","key":"e_1_2_1_16_2"},{"key":"e_1_2_1_17_2","first-page":"447","article-title":"Gegenw\u00e4rtiger Stand der Immunsuppression bei der Organtransplantation","volume":"59","author":"Wonigeit K.","year":"1988","journal-title":"Chirurgie"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-70607-3_67"},{"key":"e_1_2_1_19_2","first-page":"49","volume-title":"Therapeutic plasma exchange and selective plasma separation","author":"Bambauer R.","year":"1987"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0955-3886(89)90021-0"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370416"},{"key":"e_1_2_1_22_2","first-page":"226","article-title":"Ciclosporin bei der Behandlung von Autoimmunerkrankungen","volume":"46","author":"Schiel R.","year":"1995","journal-title":"Med Welt"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1994.tb02204.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889501800606"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205213262101"},{"key":"e_1_2_1_26_2","first-page":"19","article-title":"Stellenwert der Plasmaseparation zur Behandlung von Nierenerkrankungen","volume":"12","author":"Siebert HG","year":"1983","journal-title":"Mitt Klin Nephrol"},{"key":"e_1_2_1_27_2","first-page":"97","article-title":"Plasmapheresis in glomerulonephritis","volume":"12","author":"McKenzie PE","year":"1979","journal-title":"Clin Nephrol"},{"key":"e_1_2_1_28_2","first-page":"1806","article-title":"Interkt de L'\u00e9change plasmatique dans le traitement du syndrome de Beh\u00e7et et de ses manifestations oculaires","volume":"11","author":"Hoang P.","year":"1982","journal-title":"Nouv Presse Med"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1594.1997.tb00512.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1594.1997.tb00512.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T06:11:03Z","timestamp":1740291063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1594.1997.tb00512.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["10.1111\/j.1525-1594.1997.tb00512.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1594.1997.tb00512.x","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"type":"print","value":"0160-564X"},{"type":"electronic","value":"1525-1594"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}